CoagulationDisorders near Brick, NJ

Biography: Dr. Rama Sudhindra, MD is a Hematology Specialist who practices in Willingboro, NJ. He is 77 years old and has been practicing for 54 years. Dr. Rama Sudhindra, MD is affiliated with Cooper University Hospital and Cooper University Hospital.

Care Philosophy: I believe that it is a privilege to take care of patients who have cancer. Patients deserve to be treated with care and respect. I give my patients the time they need to discuss all of their concerns, without rushing them. My patients have access to my personal cell phone number. Staying current on all of the latest clinical research is important to me, as is collaboration with subspecialists in order to ensure the best possible care.

Care Philosophy: Qun Dai, MD, PhD is a medical oncologist and hematologist at Staten Island University Hospital. She specializes in treating breast cancer and provides personalized care to ensure the best outcomes. She uses clinical assessment, biomarker features and genomic prediction to determine the appropriate treatment for her patients. She also uses molecular assays, such as next generation sequencing and immune markers, to identify additional treatment options. She emphasizes both treatment outcomes and patient quality of life. At Northwell Health, Dr. Dai works with a multidisciplinary team of doctors regularly and collaborates with breast surgeons, radiation oncologists, radiologists, pathologists, and genetic counselors to create individualized treatment plans. Dr. Dai is also devoted to breast cancer prevention. She sees patients at high risk for breast cancer due to family history, atypical hyperplasia, and lobular carcinoma in situ (LCIS). She provides recommendations for risk reduction measures. While she focuses on breast cancer, Dr. Dai also provides care for the patients with gynecologic malignancies such as ovarian cancer, uterine cancer, cervical cancer, and other types of solid tumors, as well as malignant and benign hematologic disorders. She is actively involved in clinical cancer research and participates in both institutional and nationwide clinical trials. She has published in peer-reviewed medical journals and is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Dai earned her medical degree from Nanjing Medical College in China and completed her residency in internal medicine at the Mount Sinai School of Medicine/Bronx VA Medical Center. She received fellowship training in hematology and oncology at the Montefiore Medical Center/Albert Einstein College of Medicine. She also earned a PhD in molecular biology at the New York University School of Medicine. She is now an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Dai finds helping her patients the most rewarding. I work to establish a good connection with my patients and their families so I can support them as they are going through their treatment process, she says.

Care Philosophy: Dr. Brown prides himself in being able to educate and provide emotional support to his patients and their families. He believes educating patients is a crucial part of their treatment plan and will allow the patient to become an active participant in their care. Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Biography: Dr. Pearse is a graduate of Dartmouth College and of the combined MD/PhD program at Cornell University Medical College. He completed a Hematology and Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center from 1991-1993 and was an Instructor at Memorial Sloan Kettering Cancer Center and Cornell from 1993-1998, participating in the MSKCC autologous bone marrow transplant program and lymphoma/myeloma program. He was Guest Investigator at Rockefeller from 1997-2000, where he did important and creative work on the role of TNF receptor family members in myeloma and bone biology. In 2000, he joined the Division of Hematology and Medical Oncology to join the Multiple Myeloma Program and establish a basic science laboratory.Dr. Pearse has been an attending physician in the Division of Lymphoma/Myeloma Service, Leukemia Service, and Transplant Service since 2000. He is an expert in the clinical management of hematologic malignancies, specifically myeloma, and plays an important clinical role on our autologous and allogeneic bone marrow transplantation unit.Dr. Pearse is nationally recognized for his research on the pathobiology of multiple myeloma.